Bringing the fundamentals into focus…
Back to Telix Pharmaceuticals Limited
How Telix Pharmaceuticals Limited stacks up
TLX · against 329 other Healthcare companies of similar size
Profitability
41/ 100
Below the middle of the pack.
Ranked #220 of 330 · scores higher than 33% of peers
Bars: peers in each 10-point band of the profitability score27 peers with a profitability score of 40–49, including TLX · Click a bar to see the companies
Why profitability scores 41?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- a lower return on assets: weaker than 61% of peers. Return on assets: -0.6% vs peer median 1.7%
- Operating margin is close to the peer norm. Operating margin: 3.7% vs peer median 7.1%
- Return on invested capital is close to the peer norm. Return on invested capital: 3.5% vs peer median 4.7%
Metric by metric
Position: dot = TLX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TLX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 316 reported | 3.5% | 7.0% | 37% | 33% | |
| Operating marginHigher is better · 306 reported | 3.7% | 9.6% | 33% | 33% | |
| Return on assetsHigher is better · 314 reported | -0.6% | 2.4% | 35% | 33% | |
| Return on equityHigher is better · 305 reported | 7.4% | 6.5% | 55% | Context only | |
| Gross marginHigher is better · 338 reported | 47.6% | 49.0% | 49% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around TLX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 214 | 3.0B CHF (≈$3.5B) | 44 | 33 | |
| 218 | 428.3B JPY (≈$2.9B) | 43 | 59 | |
| 219 | 3.1B USD | 42 | 53 | |
| 220 | 4.0B USD | 41 | 46 | |
| 220 | 3.1B USD | 41 | 46 | |
| 222 | 5.8B USD | 40 | 38 | |
| 222 | 1.5B EUR (≈$1.6B) | 40 | 44 | |
| 224 | 3.0B USD | 39 | 35 | |
| 224 | 2.7B USD | 39 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score